Carregando…
Mobia Medical, Inc.
Como a empresa evoluiu, ano a ano. Receita e dívida vêm dos relatórios anuais — na maioria das empresas, os 10-K entregues à SEC desde 2009; os dividendos, dos próprios pagamentos.
As barras são um saldo na data de fechamento; as linhas são o que aconteceu ao longo do ano. Receita acima do patrimônio é o normal, não anomalia — significa que a empresa gira o capital mais de uma vez por ano.
Grandes gestores que reportaram esta ação no 13F mais recente.
Nenhum dos investidores acompanhados reportou posição em MOBI.
Empresas de tamanho parecido em Healthcare, para comparar. As colunas são as mesmas de cima, na mesma ordem.
| Ação | Preço | P/L | P/VP | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SABSSAB Biotherapeutics, Inc. | $3.22 | 13.4x | 1.3x | — | -11.27% | $292.52M |
| TMCITreace Medical Concepts Inc | $4.48 | — | 4.3x | — | -71.99% | $291.35M |
| UPBUpstream Bio, Inc. | $5.30 | — | 1.1x | — | -46.05% | $290.29M |
| CUVLClinuvel Pharmaceuticals Ltd |
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Descrição da empresa fornecida pelo Yahoo Finance. A descrição é publicada pela fonte apenas em inglês.
| $5.75 |
| 12.2x |
| 1.5x |
| 0.70% |
| 13.21% |
| $289.96M |
| XFORX4 Pharmaceuticals, Inc | $3.02 | 2.1x | 1.9x | — | -113.08% | $298.93M |
| RCKTRocket Pharmaceuticals Inc | $2.61 | — | 0.8x | — | -4.77% | $286.51M |